Blog: Blog2

GPCR News

Feb 28, 20221 min read

Inversago Pharma Announces Dosing of First Participant with Metabolic Syndrome in Phase 1B ...

March 2022 Inversago Pharma Announces Dosing of First Participant with Metabolic Syndrome in Phase 1B Clinical Trial "MONTREAL (CANADA) –...